TEX-VAL: Texas A&M Tissue Chip Validation Center

TEX-VAL：德克萨斯 A

• 批准号: 9275097
• 负责人: Ivan Rusyn
• 金额: $ 212.13万
• 依托单位: TEXAS A&M UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-23 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9275097
• 关键词: Academia; Address; Analytical Chemistry; Animal Testing; Animals; Bacteria; Biological Assay; Biological Sciences; Biomedical Engineering; Cells; Characteristics; Chemical Industry; Chemicals; Collaborations; Complex; Contract Services; Data; Data Analyses; Data Quality; Data Storage and Retrieval; Databases; Decision Making; Development; Dose; Drug Industry; Economics; Ensure; Europe; Federal Government; Genomics; Geoscience; Goals; Government; Government Agencies; Hazard Identification; Human; Human Resources; Image; In Vitro; Industry; Informatics; Institute of Medicine (U.S.); Institutes; International; Laboratories; Language; Lead; Measurement; Methodology; Methods; Microfluidics; Microscopy; Modeling; National Toxicology Program; Organ; Organism; Outcome; Performance; Phenotype; Procedures; Process; Production; Protocols documentation; Qualifying; Reading; Records; Regulation; Reporting; Reproducibility; Research; Research Infrastructure; Research Personnel; Resources; Risk Assessment; Safety; Science; Scientist; Staging; Standardization; State Government; System; Technology; Testing; Texas; Time; Tissue Microarray; Tissues; Toxicity Tests; Toxicology; United States Food and Drug Administration; United States National Institutes of Health; Universities; Validation; Veterinary Medicine; base; cell type; college; drug testing; experience; fitness; high standard; in vitro testing; in vivo; interest; mathematical model; member; metabolomics; novel; operation; pharmacokinetic model; programs; public health relevance; quality assurance; research study; response; screening; sound

PROJECT DESCRIPTION TEX-VAL: Texas A&M Tissue Chip Validation Center This proposal is to establish a Tissue Chip Validation Center at Texas A&M University (TEX-VAL) which will conduct testing of the microphysiological systems developed by NIH grantees. Our goal is to provide resources, personnel and infrastructure for establishing functionality, reproducibility, robustness and reliability of 8-12 tissue chip models that will represent a wide array of human organ and tissue systems. To achieve this goal we have assembled a team of 7 outstanding investigators who specialize in toxicology, in vitro and in vivo testing, microscopy, genomics, pharmacokinetic modeling, bioengineering, analytical chemistry and risk assessment. These investigators will closely oversee a team of highly qualified staff members who, in collaboration with tissue chip developers, will conduct validation experiments, analyze data, generate detailed reports and ensure that the data are available to the NIH Tissue Chip Program through an accessible database. Quality management plan and quality assurance project plans will be developed and overseen by a staff member with experience in these procedures and applicable regulations. All experimental protocols and data records will adhere to the highest standards based on the existing Organization for Economic Cooperation and Development (OECD) guidance for describing non-guideline in vitro test methods, as well as appropriate guidance on validation of alternatives to animal methods from the Food and Drug Administration and the National Toxicology Program. The TEX-VAL Center will utilize Texas A&M University's existing extensive infrastructure for medium- and high-throughput in vitro screening and high-content imaging at the Institute for Biosciences and Technology (Houston, TX) and College of Veterinary Medicine and Biomedical Sciences (College Station, TX), analytical chemistry at the Geosciences and Environmental Research Group (College Station, TX), and bioengineering and microfluidics at the NanoBio Systems Laboratory (College Station, TX). TEX-VAL Center will engage with the NIH tissue chip grantees and the IQ Consortium, as well as additional experts in the pharmaceutical and chemical industry, government agencies and academia to address questions on tissue chip validation, in vitro to in vivo concordance, untargeted metabolomics analyses, selection of appropriate cell types, experimental protocols, or selection of appropriate test compounds and positive and negative controls. The laboratories and investigators involved in the TEX-VAL have decades of experience with rigor, reproducibility and replication of data through multi-disciplinary research collaborations and service contracts with industry, state and federal government, and academic collaborators. In addition, TEX-VAL has an extensive network of partnerships with regulatory agencies in the USA and Europe already in place, which will serve as an important channel for engagement with diverse stakeholders to communicate the scientific promise and technical robustness, as well as any important limitations, of the tested tissue chips.

项目说明 德州农工组织芯片验证中心 这项提议是在德克萨斯农工大学(Tex-Val)建立组织芯片验证中心，该中心将 对NIH受赠者开发的微生理系统进行测试。我们的目标是提供 用于建立功能性、重复性、稳健性和可靠性的资源、人员和基础设施 8-12个组织芯片模型，将代表广泛的人体器官和组织系统。要做到这一点 目标我们已经组建了一支由7名优秀的研究人员组成的团队，他们专门从事体外和体内的毒理学研究。 测试、显微镜、基因组学、药代动力学建模、生物工程、分析化学和风险 评估。这些调查人员将密切监督一支高素质的工作人员团队，他们在 与组织芯片开发商合作，将进行验证实验，分析数据，生成详细的 报告并确保NIH组织芯片计划通过可访问的 数据库。质量管理计划和质量保证项目计划将由 具有这些程序和适用法规经验的工作人员。所有实验方案和 数据记录将遵循基于现有经济合作组织的最高标准 描述非指南体外试验方法的指南和开发(OECD)指南 美国食品和药物管理局和美国食品和药物管理局关于动物方法替代品验证的指南 国家毒理学计划。Tex-Val中心将利用德克萨斯农工大学现有的广泛 用于中高通量体外筛选和高含量成像的基础设施 生物科学与技术(德克萨斯州休斯顿)和兽医与生物医学学院 (德克萨斯州大学站)，地球科学和环境研究小组(学院)分析化学 以及纳米生物系统实验室(德克萨斯州大学站)的生物工程和微流体学。 Tex-Val中心将与NIH组织芯片受赠者和IQ财团以及其他 制药和化工行业、政府机构和学术界的专家将发表讲话 关于组织芯片验证、体外与体内一致性、非靶向代谢组学分析、 选择适当的细胞类型、实验方案或选择适当的测试化合物和 阳性对照和阴性对照。参与Tex-Val的实验室和调查人员已经有几十年的 通过多学科研究协作在数据的严密性、重复性和复制性方面的经验 以及与行业、州和联邦政府以及学术合作者签订的服务合同。此外, Tex-Val与美国和欧洲的监管机构建立了广泛的合作网络，目前已 它将成为与不同利益攸关方接触的重要渠道，以沟通 被测试组织芯片的科学前景和技术稳健性，以及任何重要的限制。